Investigation of new biomarkers of kidney injury in renal transplant recipients undergoing graft biopsy
Clinical Transplantation2021Vol. 35(9), pp. e14408–e14408
Citations Over Time
Arthur Michon, Antoine Dürrbach, Jean‐Charles Gautier, Xavier Benain, Catherine Lunven, Alexandre Jagerschmidt, C. Aubert, Oliver Poetz, Thomas Joos, Thierry Gury, Laurent Becquemont
Abstract
The new BM did not outperform classical BM in the context of renal transplantation. Urinary NGAL may be useful for distinguishing between ATN and acute rejection.
Related Papers
- → Donor Kidney Volume and Outcomes Following Live Donor Kidney Transplantation(2006)159 cited
- → Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy(2010)47 cited
- → A Simple Method to Detect Recovery of Glomerular Filtration Rate following Acute Kidney Injury(2014)11 cited
- → Assessment of Renal Function Using Cystatin C and Creatinine in Saudi Patients after Transplantation(2021)5 cited
- → Does Allograft Size Really Matter in the Long-Term Outcome of Living Donor Kidney Transplantation?(2015)5 cited